Cargando…

Preliminary Analysis of Cervical Cancer Immunotherapy

Cervical cancer is one of the most common gynecologically malignancies worldwide. Although vaccine and cervical cancer screening including human papillomavirus testing, cytology testing, and colposcopy have developed rapidly in recent years, effectively reducing cervical cancer mortality, cervical c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Zhen, Zou, Xinxin, Yan, Zhaohua, Chen, Caiyun, Chen, Yumei, Fu, Aizhen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624377/ https://www.ncbi.nlm.nih.gov/pubmed/36301242 http://dx.doi.org/10.1097/COC.0000000000000950

Ejemplares similares

Primary malignant melanoma of the cervix: A comprehensive analysis of case reports in the Chinese population
por: Ye, Yuan, et al.
Publicado: (2023)

Mucinous Ovarian Tumors With Anaplastic Mural Nodules: Case Report
por: Zou, Xinxin, et al.
Publicado: (2021)

Combinations of radiotherapy with immunotherapy in cervical cancer
por: Yang, Xiaojing, et al.
Publicado: (2022)

Immunotherapy for Uterine Cervical Cancer
por: Kagabu, Masahiro, et al.
Publicado: (2019)

Prognostic value of SOX9 in cervical cancer: Bioinformatics and experimental approaches
por: Chen, Huan, et al.
Publicado: (2022)

Targeting STAT3 in Cancer Immunotherapy
por: Zou, Sailan, et al.
Publicado: (2020)

Applying artificial intelligence for cancer immunotherapy
por: Xu, Zhijie, et al.
Publicado: (2021)

γδ T cells in cancer immunotherapy
por: Zou, Chang, et al.
Publicado: (2016)

Immunotherapy for Cervical Cancer: Are We Ready for Prime Time?
por: Turinetto, Margherita, et al.
Publicado: (2022)

NK Cell Regulation in Cervical Cancer and Strategies for Immunotherapy
por: Gutiérrez-Hoya, Adriana, et al.
Publicado: (2021)

T cell immunotherapy for cervical cancer: challenges and opportunities
por: Yu, Lingfeng, et al.
Publicado: (2023)

Targeting the RNA m(6)A modification for cancer immunotherapy
por: Li, Xinxin, et al.
Publicado: (2022)

Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational research
por: Lee, Sung-Jong, et al.
Publicado: (2016)

Advances in immunotherapy for cervical cancer
por: Grau-Bejar, Juan Francisco, et al.
Publicado: (2023)

The Notch signaling pathway: a potential target for cancer immunotherapy
por: Li, Xinxin, et al.
Publicado: (2023)

Immunotherapy for Uterine Cervical Cancer Using Checkpoint Inhibitors: Future Directions
por: Kagabu, Masahiro, et al.
Publicado: (2020)

The Role of Immunotherapy in the Treatment of Advanced Cervical Cancer: Current Status and Future Perspectives
por: Walsh, Robert J., et al.
Publicado: (2021)

Ferroptosis in cancer and cancer immunotherapy
por: Zhao, Lei, et al.
Publicado: (2022)

Immune Environment and Immunotherapy in Endometrial Carcinoma and Cervical Tumors
por: Lainé, Alexandra, et al.
Publicado: (2023)

Neoantigen: A Promising Target for the Immunotherapy of Colorectal Cancer
por: Zheng, Yue, et al.
Publicado: (2022)

Patient-derived organoids as personalized avatars and a potential immunotherapy model in cervical cancer
por: Huang, Hua, et al.
Publicado: (2023)

From the Infection to the Immunotherapy in Cervical Cancer: Can We Stop the Natural Course of the Disease?
por: Luvero, Daniela, et al.
Publicado: (2020)

Immunotherapy Strategies Against Multiple Myeloma
por: Ma, Jing, et al.
Publicado: (2017)

Immunotherapy in cervical cancer: the advent of precision medicine
por: De Felice, Francesca, et al.
Publicado: (2020)

Efficacy and Safety of Immunotherapy for Cervical Cancer—A Systematic Review of Clinical Trials
por: Schmidt, Mona W., et al.
Publicado: (2022)

The Interplay between T Cells and Cancer: The Basis of Immunotherapy
por: Chen, Christina, et al.
Publicado: (2023)

Tumor purity as a prognosis and immunotherapy relevant feature in cervical cancer
por: Deng, Yali, et al.
Publicado: (2021)

Immunotherapy in cervical cancer: From the view of scientometric analysis and clinical trials
por: Xing, Yang, et al.
Publicado: (2023)

Immunotherapy for Colorectal Cancer
por: Boland, Patrick M., et al.
Publicado: (2017)

Review Article: Immune Landscape and Immunotherapy Options in Cervical Carcinoma
por: Kousar, Kousain, et al.
Publicado: (2022)

A preliminary cervical cancer screening cascade for eight provinces rural Chinese women: a descriptive analysis of cervical cancer screening cases in a 3-stage framework
por: Wang, Shu-Xia, et al.
Publicado: (2019)

Pan-cancer analysis and experimental validation of DTL as a potential diagnosis, prognosis and immunotherapy biomarker
por: Tang, Yumei, et al.
Publicado: (2023)

Harnessing Metabolic Reprogramming to Improve Cancer Immunotherapy
por: Yan, Liang, et al.
Publicado: (2021)

Nanomedicine Strategies for Heating “Cold” Ovarian Cancer (OC): Next Evolution in Immunotherapy of OC
por: Yang, Yuqi, et al.
Publicado: (2022)

Signatures of immune cell infiltration for predicting immune escape and immunotherapy in cervical cancer
por: Chen, Fuxing, et al.
Publicado: (2023)

DNA vaccine for cancer immunotherapy
por: Yang, Benjamin, et al.
Publicado: (2015)

Bibliometric Analysis of Hotspots and Frontiers of Immunotherapy in Pancreatic Cancer
por: Xu, Qiong, et al.
Publicado: (2023)

New Immunotherapy Strategies in Breast Cancer
por: Yu, Lin-Yu, et al.
Publicado: (2017)

Study on the correlation between hTREC and HPV load and cervical CINI/II/III lesions and cervical cancer
por: He, Haizhen, et al.
Publicado: (2020)

Statistical Analysis and Preliminary Study on the Mix Proportion Design of Self-Compacting Steel Fiber Reinforced Concrete
por: Ding, Xinxin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_21tm7mu06o6m8tib2tamu683pe